• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Molecular mimicry in multisystem inflammatory syndrome in children; Bodansky et al.; August 2024

Mary

Moderator Resource
Messages
17,742
Location
Texas Hill Country

Molecular mimicry in multisystem inflammatory syndrome in children


Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection1,2, yet the pathophysiological mechanism connecting the infection to the broad inflammatory syndrome remains unknown. Here we leveraged a large set of samples from patients with MIS-C to identify a distinct set of host proteins targeted by patient autoantibodies including a particular autoreactive epitope within SNX8, a protein involved in regulating an antiviral pathway associated with MIS-C pathogenesis. In parallel, we also probed antibody responses from patients with MIS-C to the complete SARS-CoV-2 proteome and found enriched reactivity against a distinct domain of the SARS-CoV-2 nucleocapsid protein. The immunogenic regions of the viral nucleocapsid and host SNX8 proteins bear remarkable sequence similarity. Consequently, we found that many children with anti-SNX8 autoantibodies also have cross-reactive T cells engaging both the SNX8 and the SARS-CoV-2 nucleocapsid protein epitopes. Together, these findings suggest that patients with MIS-C develop a characteristic immune response to the SARS-CoV-2 nucleocapsid protein that is associated with cross-reactivity to the self-protein SNX8, demonstrating a mechanistic link between the infection and the inflammatory syndrome, with implications for better understanding a range of post-infectious autoinflammatory diseases.


This just caught my eye. I don't have the energy to really look at it right now but thought some here might be able to parse this.
 

Mary

Moderator Resource
Messages
17,742
Location
Texas Hill Country
Thanks @kushami - that's where I first read about the study :) Then I looked up the actual study from there. I'm still too tired to read either the article or the study but will look more closely when I'm able to -
 

kushami

Senior Member
Messages
298
Thanks @kushami - that's where I first read about the study :) Then I looked up the actual study from there. I'm still too tired to read either the article or the study but will look more closely when I'm able to -

Oh, of course!

Sadly I am prohibited by the paywall, or I would have attempted a quick precis.

I used to be able to read a couple of NY Times articles a month for free. Then I subscribed for a while, then stopped, and now I can’t get back the previous occasional free access. Harumph.

I did read every “Diagnosis” article I could find in the archive while subscribed, so got my money’s worth.
https://www.nytimes.com/column/diagnosis

Didn’t help to diagnose me but I now know about a bunch of obscure (and less-obscure-but-commonly-missed) medical conditions.

For anyone else who likes reading this kind of stuff, there is a similar column called “Medical Mysteries” in the Washington Post.
https://www.washingtonpost.com/health/medical-mysteries/
 
Back